主要学习及工作经历 1995-1999，内蒙古医学院药学系 获理学学士学位 1999-2002，内蒙古医学院药理学专业 获医学硕士学位 2002-2005，北京大学医学部基础医学院药理学系 获理学博士学位 2005-2015，北京大学医学部基础医学院药理学系 讲师 2006-2007，日本德岛大学药理学系 访问学者 2015-至今，北京大学医学部基础医学院药理学系 副教授

主要学术任职 担任中国药理学会教学与科普专业委员会秘书长，生化与分子药理委员会委员。《中国药理通讯》杂志责任编辑。担任 Pharmaceutical Biology，药学学报等国内外学术杂志的审稿工作。

获奖情况 中国药理学会-法国施维雅青年药理学家奖、中国药理学会优秀青年药理学工作者奖、北京大学医学部优秀教师、北京大学基础医学院青年教师奖励基金等

研究方向 肿瘤转移和耐药的分子药理学研究

基金来源 国家自然科学基金项目（No. 30901815）

代表论文 1.Pan Y, Li X, Duan J, Yuan L, Fan S, Fan J, Xiaokaiti Y, Yang H, Wang Y, Li X. Enoxaparin Sensitizes Human Non-Small-Cell Lung Carcinomas to Gefitinib by Inhibiting DOCK1 Expression, Vimentin Phosphorylation, and Akt Activation. Mol Pharmacol. 2015 Mar;87(3):378-90. 2.Pan Y, Zhong LJ, Zhou H, Wang X, Chen K, Yang HP, Xiaokaiti Y, Maimaiti A, Jiang L, Li XJ. Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis. Acta Pharmacol Sin. 2012 Jun;33(6):798-808. 3.Pan Y, Lei T, Teng B, Liu J, Zhang J, An Y, Xiao Y, Han J, Pan X, Wang J, Yu H, Ren H, Li X. Role of vimentin in the inhibitory effects of low-molecular-weight heparin on PC-3M cell adhesion to, and migration through, endothelium. J Pharmacol Exp Ther. 2011 Oct;339(1):82-92. 4.Ma B, Pan Y, Song Q, Tie L, Zhang Y, Xiao Y, Zhang J, Han J, Xu Y, Xiang Y, Yu HM, Li XJ. The effect of topiramate on tumor-related angiogenesis and on the serum proteome of mice bearing Lewis lung carcinoma. Eur J Pharmacol. 2011 Aug 1;663(1-3):9-16. doi: 10.1016/j.ejphar.2011.04.056. Epub 2011 May 17. Erratum in: Eur J Pharmacol. 2012 Mar 5;678(1-3):86. 5.Pan Y, Iwata F, Wang D, Muraguchi M, Ooga K, Ohmoto Y, Takai M, Cho G, Kang J, Shono M, Li XJ, Okamura K, Mori T, Ishikawa Y. Identification of aquaporin-5 and lipid rafts in human resting saliva and their release into cevimeline-stimulated saliva. Biochim Biophys Acta. 2009 Jan 1;1790(1):49-56. 6.Pan Y, Song QL, Lin YH, Lu N, Yu HM, Li XJ. GLB prevents tumor metastasis of Lewis lung carcinoma by inhibiting tumor adhesion actions. Acta Pharmacol Sin. 2005;26(7):881-6. 7.Maimaiti A, Abudoukeremu K, Tie L, Pan Y, Li X. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia. Gene. 2015 Mar 10;558(2):271-7. 8.Fan S, Xu Y, Li X, Tie L, Pan Y, Li X. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies. Biochim Biophys Acta. 2014 Sep;1842(9):1742-54. 9.Fan S, Pan Z, Geng Q, Li X, Wang Y, An Y, Xu Y, Tie L, Pan Y, Li X. Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles. PLoS One. 2013 Jun 25;8(6):e67142. 10.Lin YH, Liu AH, Pan Y, Westenbroek C, Ter Horst GJ, Yu HM, Li XJ. Reduction in the in vitro expression of Brain-Pancreas Relative Protein by oxygen and glucose-deprivation. Mol Cell Biochem. 2006; 295(1-2):199-204.